G6PD NanKang (517 T-->C; 173 Phe-->Leu): a new Chinese G6PD variant associated with neonatal jaundice

Hum Hered. 1996 Jul-Aug;46(4):201-4. doi: 10.1159/000154354.

Abstract

Using a non-radioactive PCR-SSCP technique, we identified a novel glucose-6-phosphate dehydrogenase (G6PD) mutation in a Chinese newborn with neonatal jaundice. This new variant (G6PD NanKang) causes a T to C change at nucleotide position 517, producing a Phe173Leu substitution in the human G6PD protein. Since the 517 mutation does not create or remove any known restriction site, we introduced an artificially created site by adding a primer containing a mismatched base to the PCR reaction mixture. The mismatched base accompanying the nearby 517 T-->C mutation generates an XhoI site which is suitable for distinguishing normal from mutant alleles. Using this approach, the 517 mutation can be diagnosed quickly at the DNA level.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fetal Blood
  • Genetic Variation / genetics
  • Glucosephosphate Dehydrogenase / genetics*
  • Glucosephosphate Dehydrogenase Deficiency / complications*
  • Glucosephosphate Dehydrogenase Deficiency / genetics*
  • Haplotypes
  • Humans
  • Infant, Newborn
  • Jaundice, Neonatal / etiology*
  • Male
  • Point Mutation*
  • Polymerase Chain Reaction / methods
  • Polymorphism, Single-Stranded Conformational

Substances

  • Glucosephosphate Dehydrogenase